Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT05485350 · UNKNOWN
Trial details
- NCT number
- NCT05485350
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-12
- Primary completion
- 2023-09-21
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.